Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study

Autor: J. Lambea Sorrosal, Grupo Español de Tratamiento de Tumores de Cabeza y Cuello, B. Cirauqui Cirauqui, A Lozano Borbalas, L. C. Iglesias Docampo, José A. Caballero, J Marruecos Querol, J M Ponce Ortega, M. Taberna Sanz, M. Plana Serrahima, I. Planas Toledano, E Ortega Izquierdo, Javier Martinez-Trufero, J C Adansa, I. Pajares Bernad, R. Mesia Nin, Jordi Rubió-Casadevall

Publikováno v: Clinical and Translational Oncology. 23:1666-1677

Sequential treatment of Panitumumab (Pb) plus Paclitaxel (Px) as induction treatment (IT) followed by concurrent bioradiotherapy (Bio–RT) with Pb may be an alternative for locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c792b41bdfce6fa7aa9d9a6c7234d459
https://doi.org/10.1007/s12094-021-02567-z

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial

Autor: R, Hitt, L, Iglesias, A, López-Pousa, A, Berrocal-Jaime, J J, Grau, C, García-Girón, J, Martínez-Trufero, M, Guix, J, Lambea-Sorrosal, E, Del Barco-Morillo, X, León-Vintró, A J, Cunquero-Tomas, N, Baste, A, Ocaña, J J, Cruz-Hernández

Publikováno v: Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 23(4)

Our previous phase-3 study (TTCC 2503) failed to show overall survival advantage of 2 induction chemotherapy (IC) regimens followed by standard concurrent chemoradiotherapy (CRT) over CRT alone in patients with unresectable locally advanced head and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a51739048a34ea3e4aaaa8309971bbb4
https://pubmed.ncbi.nlm.nih.gov/32797376

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

Autor: Antonio Rueda, B. Cirauqui Cirauqui, A. Carral Maseda, J. J. Lambea Sorrosal, J.J. Cruz Hernandez, V. Arrazubi Arrula, L. C. Iglesias Docampo, Y. Escobar, M. Pastor Borgoñón, N. Baste Rotllan

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Clinical & Translational Oncology
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname

Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c789eb5c1a24b3c6ce509594a6e4504c
https://hdl.handle.net/20.500.12530/29659

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Evaluation of nausea, vomiting, and diarrhea in oncologic patients at the emergency department

Autor: M. Ruiz-Echarri Rueda, A. I. Ferrer Perez, S. Serrano Solares, A. Tres Sánchez, E. Millastre Bocos, J. Lambea Sorrosal, M. J. Vidal Losada, D. Lopez Sanchez, I. Pajares Bernad, M. Tobeña Puyal

Publikováno v: Journal of Clinical Oncology. 27:e20727-e20727

e20727 Background: Nausea, vomiting, and diarrhea are very common in cancer patients under palliative treatment. These usually can be controlled on an outpatient basis, although they can become extremely debilitating for the patient. It is not uncomm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79f360817ce5f7073529a554a56b92d7
https://doi.org/10.1200/jco.2009.27.15_suppl.e20727